trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Sekita N et al. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. 2001 Jpn. J. Cancer Res. pmid:11572762
Yin L et al. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. 2001 J. Biol. Chem. pmid:11572859
Leng SL et al. Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo. 2001 Carcinogenesis pmid:11577001
Yang X et al. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. 2001 Cancer Res. pmid:11585728
Abderrahmani A et al. The transcriptional repressor REST determines the cell-specific expression of the human MAPK8IP1 gene encoding IB1 (JIP-1). 2001 Mol. Cell. Biol. pmid:11585908
Yoshida M et al. Histone deacetylase as a new target for cancer chemotherapy. 2001 Cancer Chemother. Pharmacol. pmid:11587361
Ferraro M et al. Involvement of histone H4 acetylation in the epigenetic inheritance of different activity states of maternally and paternally derived genomes in the mealybug Planococcus citri. 2001 Chromosoma pmid:11453559
Marianna P et al. Valproic acid, trichostatin and their combination with hemin preferentially enhance gamma-globin gene expression in human erythroid liquid cultures. 2001 Haematologica pmid:11454524
Cho JH et al. DNA methylation regulates placental lactogen I gene expression. 2001 Endocrinology pmid:11459782
Walker GE et al. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. 2001 Endocrinology pmid:11517158
Jorgensen JS and Nilson JH AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein-protein interactions with cJun and activation transcription factor 2. 2001 Mol. Endocrinol. pmid:11518798
Phiel CJ et al. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. 2001 J. Biol. Chem. pmid:11473107
Williams RJ Trichostatin A, an inhibitor of histone deacetylase, inhibits hypoxia-induced angiogenesis. 2001 Expert Opin Investig Drugs pmid:11785457
Benjamin D and Jost JP Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation. 2001 Nucleic Acids Res. pmid:11522830
Rashid SF et al. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. 2001 Oncogene pmid:11313934
Ma J et al. Regulation of zygotic gene activation in the preimplantation mouse embryo: global activation and repression of gene expression. 2001 Biol. Reprod. pmid:11369600
Della Ragione F et al. Genes modulated by histone acetylation as new effectors of butyrate activity. 2001 FEBS Lett. pmid:11423116
Maës J et al. Chromatin remodeling at the Ig loci prior to V(D)J recombination. 2001 J. Immunol. pmid:11441093
Wang H et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. 2001 Science pmid:11387442
Klar AJ et al. A histone deacetylation inhibitor and mutant promote colony-type switching of the human pathogen Candida albicans. 2001 Genetics pmid:11404352
Feng YQ et al. Position effects are influenced by the orientation of a transgene with respect to flanking chromatin. 2001 Mol. Cell. Biol. pmid:11113204
Mehra-Chaudhary R et al. Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter. 2001 Biochem. J. pmid:11115394
Osborne A et al. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation. 2001 Mol. Cell. Biol. pmid:11533238
Kosugi H et al. In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD / Shi-scid/scid mice. 2001 Jpn. J. Cancer Res. pmid:11376562
Chang YC et al. Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene. 2001 Mol. Cell. Biol. pmid:11158299
Newell-Price J et al. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression. 2001 Mol. Endocrinol. pmid:11158338
Kamitani H et al. Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. 2001 Carcinogenesis pmid:11159758
Shestakova E et al. Inhibition of histone deacetylation induces constitutive derepression of the beta interferon promoter and confers antiviral activity. 2001 J. Virol. pmid:11238870
Kuwahara K et al. The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. 2001 Mol. Cell. Biol. pmid:11238943
Rombouts K et al. Trichostatin A, lead compound for development of antifibrogenic drugs. 2001 Jul-Sep Acta Gastroenterol. Belg. pmid:11680040
McGuinness MC et al. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. 2001 Sep-Oct Mol. Genet. Metab. pmid:11592822
López-Solache I et al. Regulation of uncoupling protein-2 mRNA in L6 myotubules: II: Thyroid hormone amplifies stimulation of uncoupling protein-2 gene by thiazolidinediones and other peroxisome proliferator-activated receptor ligands in L6 myotubules: evidence for a priming effect. 2002 Endocrine pmid:12588052
Drewell RA et al. Methylation-dependent silencing at the H19 imprinting control region by MeCP2. 2002 Nucleic Acids Res. pmid:11861904
Murphy JC et al. Control of cytomegalovirus lytic gene expression by histone acetylation. 2002 EMBO J. pmid:11867539
Kim JY et al. Probing lysine acetylation with a modification-specific marker ion using high-performance liquid chromatography/electrospray-mass spectrometry with collision-induced dissociation. 2002 Anal. Chem. pmid:12433071
Gregory RI et al. Inhibition of histone deacetylases alters allelic chromatin conformation at the imprinted U2af1-rs1 locus in mouse embryonic stem cells. 2002 J. Biol. Chem. pmid:11821379
Elaut G et al. Major phase I biotransformation pathways of Trichostatin a in rat hepatocytes and in rat and human liver microsomes. 2002 Drug Metab. Dispos. pmid:12433798
Yáñez RJ and Porter AC A chromosomal position effect on gene targeting in human cells. 2002 Nucleic Acids Res. pmid:12433992
Takechi S et al. Chicken HDAC2 down-regulates IgM light chain gene promoter activity. 2002 Biochem. Biophys. Res. Commun. pmid:12437980
Singal R et al. Methylation of promoter proximal-transcribed sequences of an embryonic globin gene inhibits transcription in primary erythroid cells and promotes formation of a cell type-specific methyl cytosine binding complex. 2002 J. Biol. Chem. pmid:11684679
Williams RS et al. A common mechanism of action for three mood-stabilizing drugs. 2002 Nature pmid:12015604
Veilleux S and Boissonneault G Dynamics of reporter gene stimulation by HMG box proteins. 2002 DNA Cell Biol. pmid:12015897
Huang HC et al. Geldanamycin inhibits trichostatin A-induced cell death and histone H4 hyperacetylation in COS-7 cells. 2002 Life Sci. pmid:12002521
Chiocca S et al. Histone deacetylase 1 inactivation by an adenovirus early gene product. 2002 Curr. Biol. pmid:11937030
Curradi M et al. Molecular mechanisms of gene silencing mediated by DNA methylation. 2002 Mol. Cell. Biol. pmid:11940673
Kostyniuk CL et al. The ubiquitous and tissue specific promoters of the human SRC gene are repressed by inhibitors of histone deacetylases. 2002 Oncogene pmid:12214274
Hall IM et al. Establishment and maintenance of a heterochromatin domain. 2002 Science pmid:12215653
Lynch CA et al. Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation. 2002 Mol. Cancer pmid:12234381
Bereshchenko OR et al. Acetylation inactivates the transcriptional repressor BCL6. 2002 Nat. Genet. pmid:12402037
Chen Z et al. Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells. 2002 Cancer Lett. pmid:12406558